Page last updated: 2024-09-02

tadalafil and 9-(2-hydroxy-3-nonyl)adenine

tadalafil has been researched along with 9-(2-hydroxy-3-nonyl)adenine in 1 studies

Compound Research Comparison

Studies (tadalafil)	Trials (tadalafil)	Recent Studies (post-2010) (tadalafil)	Studies (9-(2-hydroxy-3-nonyl)adenine)	Trials (9-(2-hydroxy-3-nonyl)adenine)	Recent Studies (post-2010) (9-(2-hydroxy-3-nonyl)adenine)
1,742	392	1,089	30	0	11

Protein Interaction Comparison

Protein	Taxonomy	tadalafil (IC50)	9-(2-hydroxy-3-nonyl)adenine (IC50)
cGMP-dependent 3',5'-cyclic phosphodiesterase	Homo sapiens (human)		2.145

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hughes, RA; Manallack, DT; Thompson, PE	1

Reviews

1 review(s) available for tadalafil and 9-(2-hydroxy-3-nonyl)adenine

Article	Year
The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases. Journal of medicinal chemistry, 2005, May-19, Volume: 48, Issue:10 Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP; Cyclic GMP; Drug Design; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Quantitative Structure-Activity Relationship; Xanthines	2005

Article

Year

The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.

Journal of medicinal chemistry, 2005, May-19, Volume: 48, Issue:10

Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP; Cyclic GMP; Drug Design; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Quantitative Structure-Activity Relationship; Xanthines

2005